BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 37526605)

  • 1. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
    Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
    Mehata AK; Vikas ; Viswanadh MK; Muthu MS
    Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging applications of nanostructured metal-organic frameworks in cancer-targeted theranostics.
    Lakshmi BA; Kim S
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110091. PubMed ID: 31546428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
    Wu MX; Yang YW
    Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart metal organic frameworks: focus on cancer treatment.
    Falsafi M; Saljooghi AS; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Biomater Sci; 2021 Mar; 9(5):1503-1529. PubMed ID: 33428697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in Metal-Organic Frameworks as nanocarriers for triggered release of anticancer drugs: Brief history, biomedical applications, challenges and future perspective.
    Fatima SF; Sabouni R; Garg R; Gomaa H
    Colloids Surf B Biointerfaces; 2023 May; 225():113266. PubMed ID: 36947901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
    Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
    Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis.
    Li B; Ashrafizadeh M; Jiao T
    Int J Biol Macromol; 2024 Mar; 260(Pt 2):129391. PubMed ID: 38242413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-Organic Framework (MOF)-based Nanomaterials for Biomedical Applications.
    Luo Z; Fan S; Gu C; Liu W; Chen J; Li B; Liu J
    Curr Med Chem; 2019; 26(18):3341-3369. PubMed ID: 29446726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
    Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
    ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Metal-Organic Frameworks for pH-Responsive Drug Delivery Application.
    Shen X; Pan Y; Sun Z; Liu D; Xu H; Yu Q; Trivedi M; Kumar A; Chen J; Liu J
    Mini Rev Med Chem; 2019; 19(20):1644-1665. PubMed ID: 31880236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.
    He L; Liu Y; Lau J; Fan W; Li Q; Zhang C; Huang P; Chen X
    Nanomedicine (Lond); 2019 May; 14(10):1343-1365. PubMed ID: 31084393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
    Wei Q; Wu Y; Liu F; Cao J; Liu J
    J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
    Carrillo-Carrión C
    Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale MOFs: From synthesis to drug delivery and theranostics applications.
    Ding M; Liu W; Gref R
    Adv Drug Deliv Rev; 2022 Nov; 190():114496. PubMed ID: 35970275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal-organic frameworks: Drug delivery applications and future prospects.
    Mhettar P; Kale N; Pantwalawalkar J; Nangare S; Jadhav N
    ADMET DMPK; 2024; 12(1):27-62. PubMed ID: 38560715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-responsive multifunctional metal-organic framework nanoparticles for enhanced chemo-photothermal therapy.
    Feng J; Xu Z; Dong P; Yu W; Liu F; Jiang Q; Wang F; Liu X
    J Mater Chem B; 2019 Feb; 7(6):994-1004. PubMed ID: 32255104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of MOFs in pH-dependent drug delivery systems: progress in the last decade.
    De D; Sahoo P
    Dalton Trans; 2022 Jul; 51(26):9950-9965. PubMed ID: 35726742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
    Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
    Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.